70
Participants
Start Date
September 30, 2014
Primary Completion Date
June 30, 2018
Study Completion Date
June 30, 2020
Docetaxel, Cisplatin and 5-Fluorouracil
Patients will receive 6 cycles of DCF regimen (docetaxel 75 mg/m2 day, cisplatin 75 mg/m2 and 5 Fluorouracil at 750 mg/m2/day for 5 days) every 3 weeks or 8 cycles of modified-DCF regimen (docetaxel 40 mg/m2 day, cisplatin 40 mg/m2 day and 5-Fluorouracil at 1200 mg/m2/day for 2 days) every 2 weeks, according to their clinical status.
FNLCC center Georges François Leclerc, Dijon
University hospital of Besançon, Besançon
Hospital of Belfort-Montbeliard, Montbéliard
Oscar Lambret center, Lille
Saint-Antoine Hospital, Paris
Jean Mermoz Private Hospital, Lyon
Regional Institute of Cancer, Montpellier
Institute of Cancerology of Lorraine, Nancy
Antoine Lacassagne Center, Nice
Paris Saint-Joseph Hospital Group, Paris
Curie Institute, Paris
Pitié Salpétrière Hospital, Paris
Mutualist Montsouris Institute, Paris
European Georges Pompidou Hospital, Paris
University Robert Debré Hospital, Reims
Paul Strauss Center, Strasbourg
Centre Hospitalier Universitaire de Besancon
OTHER